Dupixent 200 mg/1.14 mL prefilled pen Images
Generic Name: dupilumab
This medication has been identified as Dupixent 200 mg/1.14 mL prefilled pen. It is supplied by Sanofi.
Dupixent is used in the treatment of Chronic Rhinosinusitis With Nasal Polyps; Eosinophilic Esophagitis; Prurigo Nodularis; Eczema; Asthma, Maintenance and belongs to the drug class interleukin inhibitors. Dupixent 200 mg/1.14 mL prefilled pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Dupixent
- Generic Name
- dupilumab
- Strength
- 200 mg/1.14 mL prefilled pen
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sanofi
- National Drug Code (NDC)
- 00024-5919
More about Dupixent (dupilumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (478)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.